Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

PwC selects Mohamed Kande as next Global Chair

Published

on

pwc-selects-mohamed-kande-as-next-global-chair

NEW YORK and LONDON, Dec. 4, 2023 /PRNewswire/ — The Global Board of PricewaterhouseCoopers International Limited (PwCIL) today announced that Mohamed Kande has been selected as the next Chair of the PwC Network. His four-year term, which has been ratified by PwC’s worldwide network of member firms, will commence on 1 July 2024. 

Mr. Kande, who has worked at PwC since 2011, is a member of PwC’s Global Leadership Team and has served as Global Advisory Leader since 2019. In addition, he serves as the co-leader of US Consulting Solutions. Mohamed has previously held various multi-territory leadership roles and been responsible for helping our global stakeholders and clients solve their most complex problems.

Mohamed has over 32 years of professional services experience and brings a wealth of multi-industry and multi-disciplinary experience. He is a licensed CPA, holds an MBA from the University of Chicago and earned an MS in electrical engineering from the University of Montreal and a diplôme d’ingénieur in electrical engineering from Ecole Supérieure d’Ingénieurs en Génie Electrique in France.

Lisa Sawicki, PwC Network Governance Board Chair, said: 

“Mohamed is a purpose-led leader with broad multidisciplinary experience and will bring tremendous insights and perspective to the role of Global Chair. He is committed to implementing our global strategy, our multidisciplinary operating model and collaborating closely with our partners and people to help our clients and stakeholders build trust and drive sustained outcomes. Mohamed’s global experience, commitment to diversity and inclusion and understanding of cutting-edge technologies make him the ideal Chair to guide PwC into the future.” 

Mohamed Kande, PwC Global Chair-elect, said: 

“It is a great honour to be selected as the next Global Chair of the PwC Network as we enter our 175th year in business. I look forward to working with my colleagues around the world as we continue to help our clients and stakeholders build trust, deliver quality and drive sustained outcomes. That said, the world is changing quickly and the needs of our clients, our people and the communities we live in are also changing. I am extremely confident that PwC has the right strategy, the right multidisciplinary operating model and the right values in place to help our clients through these challenges and opportunities. I look forward to building on those in the next four years.”

Mr Kande will succeed Bob Moritz, who has served as Global Chair since 2016. Bob will retire at the end of his term on 30 June 2024, concluding a four decade career at PwC. 

Lisa Sawicki, PwC Network Governance Board Chair, added:

“I want to thank Bob for all he has achieved, and will continue to achieve, in his role as Global Chair. In addition to driving PwC’s strategy, Bob has been committed to our people and exemplifies PwC values every day. As Chair, he has been a champion for diversity & inclusion, stakeholder capitalism and is a leading voice of the business community around major societal issues such as climate and skills development.” 

Bob Moritz, PwC Global Chair, said: 

“It has been an honor and a privilege to serve this great Network as Global Chair. Having worked alongside Mohamed for over a decade, I have the utmost confidence he will continue to live our values and purpose while successfully driving the Network forward.”

About PwC
At PwC, our purpose is to build trust in society and solve important problems. We’re a network of firms in 151 countries with over 360,000 people who are committed to delivering quality in assurance, advisory and tax services. Find out more and tell us what matters to you by visiting us at www.pwc.com.

Biography of Mohamed Kande

Mohamed Kande currently serves as Vice Chair PwC US – US Consulting Solutions Co-Leader and Global Advisory Leader. He also serves as the CEO of the US and Japan Consulting businesses. In these roles, he is responsible for helping clients identify value and design and deliver large-scale business-led change, from strategy to outcomes, specifically in the areas of Deals, Transformation, Cybersecurity, Privacy and Risk, Cloud and Digital and Tax Consulting.

As part of his role at the Global Advisory Leader, Mohamed played a key leadership role in driving the Network’s Alliance strategy as well as served as the executive sponsor of the Network’s investments in key capabilities such as Gen AI, managed services, and business model reinvention.

Prior to this role, Mohamed served as PwC’s US and Global Advisory Leader for the technology, media, telecoms (“TMT”) and hospitality industry sectors. His technical knowledge spans the areas of operational strategy, technology development, mergers and acquisitions and operations management.

Before joining PwC in August 2011, Mohamed was the managing partner of PRTM Management Consultants’ Europe, Middle East and South Asia business. Prior to that leadership role, he was the managing partner of PRTM’s Global Public Sector business. Mohamed also continued to be one of the senior partners in PRTM’s telecommunications and technology practice.

Prior to joining PRTM, Mohamed worked for Motorola in Chicago and for DTI Telecom in Canada, deploying and launching telecommunications networks in the USA, Europe, the Middle East, Asia and Africa.

Mohamed holds an MBA from the University of Chicago, an MS in electrical engineering from the University of Montreal and a diplôme d’ingénieur inn electrical engineering from Ecole Supérieure d’Ingénieurs en Génie Electrique in France. Mohamed became a licensed CPA in Washington, D.C., in 2022. He is on the Board of Directors of CARE, the global humanitarian organization providing disaster relief to areas in crisis, and providing long-term solutions to poverty around the world.

View original content:https://www.prnewswire.co.uk/news-releases/pwc-selects-mohamed-kande-as-next-global-chair-302003449.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024

Published

on

invitation-to-presentation-of-eqt-ab’s-q1-announcement-2024

STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826

The following files are available for download:

https://mb.cision.com/Main/87/3956826/2712771.pdf

Invitation to presentation of EQT AB’s Q1 Announcement 2024

https://news.cision.com/eqt/i/eqt-ab-group,c3285895

EQT AB Group

 

View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs

Published

on

kia-presents-roadmap-to-lead-global-electrification-era-through-evs,-hevs-and-pbvs
  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

Published

on

biovaxys-technology-corp.-provides-bi-weekly-mcto-status-update

VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.

ON BEHALF OF THE BOARD

Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html

Continue Reading

Trending